Your taskCase ScenarioAmelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second.  Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications.Assignment TasksYour task is to write a risk assessment and control document for BioGenx arising from the above scenario. Assume that BioGenX has pursued a product-first approach since inception and hasn't invested back into their underlying organisational processes and infrastructure so their cybersecurity practice is immature.The document should consist of the following four sections with the applicable word limits:Part 1: Risk Register (approx. 250 words)Part 2: Justification of Risks (approx. 500 words)Part 3: Risk Control Strategy (approx. 500 words)Part 4: Personal Reflection (approx. 250 words)Part 1: Risk Register (250 words)Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios.Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2).Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2).Note: Please present the risk register in a table formatPart 2: Justification of Risk Assessment (500 words)Requirement #4: To complete your risk assessment please justify how you identified and selected the risks. Document the assumptions and logic used to estimate probability and impact and determine confidence levels. Document the categories of impact considered and weightings applied.Part 3: Risk Control Strategy (500 words)Requirement #5: Describe your strategy for controlling one risk of your choosing from the risk register. How will you use formal, informal and technological controls to best advantage? How effective do you think the controls will be and what might be the residual risk after controls are applied? What assumptions can you make about the firm’s risk appetite? What issues might arise given the subject in the scenario is the CEO and founder of BioGenX? How can these issues be handled?Part 4: Personal Reflection (250 words)Requirement #6: Reflect on your experience doing this risk assessment. What were the key challenges you faced? How did you overcome them? How did your personal perceptions of the risks in the scenario and risk management strategies impact your estimation of risk and choice of controls for BioGenX?

Case Scenario Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage. BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage. Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries. Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second. Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste. In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it. The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications. Part 1: Risk Register Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios. Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2). Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2). Note: Please present the risk register in a table format

Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second.  Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications.

What is the human microbiome project?2.2.What is the main goal of the project?

e you passionate about biology and eager to showcase your knowledge and skills? Dive into a world of academic challenges with the Ultimate List of Biology Competitions!

Anabella is the project manager of an Engineering Project. She has realised that some of the team members lack skills in scheduling software. She sends two of her team members for Primavera P6 training, the enterprise scheduling software being used by her company. She is working in theQuestion 17Answera.Delivery Performance Domainb.Project Work Performance Domainc.Team Performance Domaind.Planning Performance Domain